Product Recalls in New Mexico

Product recalls affecting New Mexico — including food, drugs, consumer products, medical devices, and vehicles distributed to New Mexico. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,606 recalls have been distributed to New Mexico in the last 12 months.

48,595 total recalls
2,606 in last 12 months

Showing 641660 of 13,432 recalls

DrugMarch 11, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: chlorproMAZINE Hydrochloride Tablets Recalled by Glenmark Pharmaceuticals...

The Issue: CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 11, 2025· Fruit Of The Earth, Inc.

Recalled Item: CVS Health Concealing Acne Treatment Cream Recalled by Fruit Of The Earth,...

The Issue: Chemical contamination: presence of benzene

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 7, 2025· Direct Rx

Recalled Item: Duloxetine D/R Recalled by Direct Rx Due to CGMP Deviations: Presence of...

The Issue: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 7, 2025· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Super-Potent Drug: Out of specification potency results were obtained.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 7, 2025· Exela Pharma Sciences LLC

Recalled Item: 8.4% Sodium Bicarbonate Injection Recalled by Exela Pharma Sciences LLC Due...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 7, 2025· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Super-Potent Drug: Out of specification potency results were obtained.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 7, 2025· ASEGUA THERAPEUTICS LLC

Recalled Item: Sofosbuvir and Velpatasvir Recalled by ASEGUA THERAPEUTICS LLC Due to...

The Issue: Defective Container: blister packs not properly sealed resulting in tablets...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 7, 2025· Direct Rx

Recalled Item: Duloxetine D/R Recalled by Direct Rx Due to CGMP Deviations: Presence of...

The Issue: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 7, 2025· Slate Run Pharmaceuticals

Recalled Item: Cinacalcet Hydrochloride Tablets 60 mg Recalled by Slate Run Pharmaceuticals...

The Issue: CGMP deviations: The presence of nitrosamine impurity above the acceptable...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 7, 2025· Slate Run Pharmaceuticals

Recalled Item: Cinacalcet Hydrochloride Tablets 30 mg Recalled by Slate Run Pharmaceuticals...

The Issue: CGMP deviations: The presence of nitrosamine impurity above the acceptable...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 6, 2025· QuVa Pharma, Inc.

Recalled Item: fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine Recalled by...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 6, 2025· QuVa Pharma, Inc.

Recalled Item: fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine Recalled...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 6, 2025· QuVa Pharma, Inc.

Recalled Item: fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.2% ROPivacaine Recalled by...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 5, 2025· Strides Pharma, Inc.

Recalled Item: Testosterone Gel 1% Recalled by Strides Pharma, Inc. Due to Presence of...

The Issue: Presence of foreign substance: Presence of Benzene.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 5, 2025· Golden State Medical Supply Inc.

Recalled Item: PRASUGREL TABLETS Recalled by Golden State Medical Supply Inc. Due to Failed...

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 5, 2025· L'Oreal USA

Recalled Item: La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne...

The Issue: Chemical Contamination: This recall has been initiated due to detected trace...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 5, 2025· L'Oreal USA

Recalled Item: La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne...

The Issue: cGMP Deviations: The recall was initiated due to detected trace levels of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 5, 2025· L'Oreal USA

Recalled Item: La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne...

The Issue: cGMP Deviations: The recall was initiated due to detected trace levels of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 5, 2025· Strides Pharma, Inc.

Recalled Item: Testosterone Gel 1% Recalled by Strides Pharma, Inc. Due to Presence of...

The Issue: Presence of foreign substance: Presence of Benzene.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 5, 2025· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Rising Pharma Holding, Inc....

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund